{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:09:39Z","timestamp":1786986579657,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.cgh.2014.12.025","type":"journal-article","created":{"date-parts":[[2015,1,5]],"date-time":"2015-01-05T02:21:05Z","timestamp":1420424465000},"page":"1346-1352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["A Model for Predicting Development of Overt Hepatic Encephalopathy in Patients With Cirrhosis"],"prefix":"10.1016","volume":"13","author":[{"given":"Oliviero","family":"Riggio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Amodio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Farcomeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Merli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Nardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Pasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Pentassuglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Gioia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Onori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"De Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Montagnese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2014.12.025_bib1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2036.2011.04590.x","article-title":"Review article: the design of clinical trials in hepatic encephalopathy\u2013an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement","volume":"33","author":"Bajaj","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2014.12.025_bib2","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0168-8278(99)80144-5","article-title":"Prognostic significance of hepatic encephalopathy in patients with cirrhosis","volume":"30","author":"Bustamante","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2014.12.025_bib3","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/hep.510230516","article-title":"Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi)","volume":"23","author":"Merli","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2014.12.025_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2013.10.004","article-title":"Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF)","volume":"60","author":"Cordoba","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2014.12.025_bib5","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1053\/j.gastro.2010.02.015","article-title":"Persistence of cognitive impairment after resolution of overt hepatic encephalopathy","volume":"138","author":"Bajaj","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2014.12.025_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cgh.2010.10.002","article-title":"Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy","volume":"9","author":"Riggio","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2014.12.025_bib7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2036.2011.04808.x","article-title":"Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy, double-blind placebo-controlled study","volume":"34","author":"Sanyal","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2014.12.025_bib8","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/ajg.2011.157","article-title":"The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers","volume":"106","author":"Bajaj","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2014.12.025_bib9","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.cgh.2013.05.010","article-title":"Cognitive dysfunction is associated with poor socioeconomic status in patients with cirrhosis: an international multicenter study","volume":"11","author":"Bajaj","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2014.12.025_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0016-5085(77)80135-2","article-title":"Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial","volume":"72","author":"Conn","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2014.12.025_bib11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jhep.2008.04.022","article-title":"Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study","volume":"49","author":"Amodio","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2014.12.025_bib12","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A\u00a0proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.cgh.2014.12.025_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","article-title":"Time-dependent ROC curves for censored survival data and a diagnostic marker","volume":"56","author":"Heagerty","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.cgh.2014.12.025_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sim.4085","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/j.cgh.2014.12.025_bib15","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1053\/j.gastro.2009.05.056","article-title":"Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, versus placebo","volume":"137","author":"Sharma","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2014.12.025_bib16","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2014.12.025_bib17","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1440-1746.2012.07186.x","article-title":"Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose","volume":"27","author":"Sharma","year":"2012","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2014.12.025_bib18","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2004.12.028","article-title":"Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomised controlled study","volume":"42","author":"Riggio","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2014.12.025_bib19","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/hep.20905","article-title":"High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study","volume":"42","author":"Riggio","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2014.12.025_bib20","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1478-3231.2010.02293.x","article-title":"Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration","volume":"30","author":"Guevara","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2014.12.025_bib21","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1111\/j.1572-0241.2001.04130.x","article-title":"Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy","volume":"96","author":"Romero-Gomez","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2014.12.025_bib22","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1053\/j.gastro.2011.06.085","article-title":"Electroencephalography in patients with cirrhosis","volume":"141","author":"Marchetti","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2014.12.025_bib23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1053\/j.gastro.2013.12.026","article-title":"Value of critical flicker frequency and Psychometric Hepatic Encephalopathy Score in diagnosis of low-grade hepatic encephalopathy","volume":"146","author":"Kircheis","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2014.12.025_bib24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1053\/j.gastro.2010.04.057","article-title":"Improving the inhibitory control task to detect minimal hepatic encephalopathy","volume":"139","author":"Amodio","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2014.12.025_bib25","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1111\/j.1572-0241.2008.02102.x","article-title":"Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts","volume":"103","author":"Riggio","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2014.12.025_bib26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.22913","article-title":"Alterations in the functional capacity of albumin in patient with decompensated cirrhosis is associated with increased mortality","volume":"50","author":"Jalan","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2014.12.025_bib27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/CS20030357","article-title":"Reversal of diuretic-induced hepatic encephalopathy with infusion of albumin but not colloid","volume":"106","author":"Jalan","year":"2004","journal-title":"Clin Sci"},{"key":"10.1016\/j.cgh.2014.12.025_bib28","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.26338","article-title":"Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications","volume":"58","author":"Garc\u00eda-Mart\u00ednez","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2014.12.025_bib29","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1161\/STROKEAHA.110.610980","article-title":"The Albumin in Acute Stroke part 1 trial: an exploratory efficacy analysis","volume":"42","author":"Hill","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.cgh.2014.12.025_bib30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1358\/dnp.2009.22.6.1395256","article-title":"Amyloid-targeted therapeutics in Alzheimer\u2019s disease: use of human albumin in plasma exchange as a novel approach for Abeta mobilization","volume":"22","author":"Boada","year":"2009","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.cgh.2014.12.025_bib31","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/gut.2007.122176","article-title":"Pathogenetic mechanisms of hepatic encephalopathy","volume":"57","author":"H\u00e4ussinger","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2014.12.025_bib32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11011-012-9365-z","article-title":"Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study","volume":"28","author":"Merli","year":"2013","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.cgh.2014.12.025_bib33","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1186\/1756-0500-5-509","article-title":"The clinical course of alcoholic cirrhosis: effects of hepatic metabolic capacity, alcohol consumption, and hyponatremia\u2013a historical cohort study","volume":"5","author":"Jepsen","year":"2012","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.cgh.2014.12.025_bib34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cld.2011.12.008","article-title":"Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt","volume":"16","author":"Riggio","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cgh.2014.12.025_bib35","first-page":"549","article-title":"Hepatic encephalopathy after transjugular intrahepatic shunts: incidence and risk factor","volume":"90","author":"Somberg","year":"1995","journal-title":"Am J Gastroenterol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356514018382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356514018382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:17:54Z","timestamp":1761542274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356514018382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1542356514018382"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2014.12.025","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Model for Predicting Development of Overt Hepatic Encephalopathy in Patients With Cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2014.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}